Winner of 2022 Healthcare & Pharmaceutical Awards
Dotmatics was named “Best Scientific R&D Software Developer & Cloud Vendor” at the 2022 Global Health & Pharma’s Healthcare & Pharmaceutical Awards for its integrated R&D platform that addresses scientific data challenges and supports over 2 million scientists worldwide in accelerating life-saving research amid the heightened demands highlighted by the COVID-19 pandemic.
Dotmatics Named “Best Scientific R&D Software Developer & Cloud Vendor”
Recently, the health and wellbeing of millions around the world has been under increased threat due to the pandemic. In many ways, the COVID-19 crisis highlighted critical industry challenges that have been growing for decades, in particular the need for rapid acceleration of scientific research and collaboration to produce faster, more successful breakthroughs.
Now in its eighth year, in 2022 the Global Health & Pharma’s Healthcare & Pharmaceutical Award recognized and awarded companies and individuals who served a variety of purposes during the pandemic—from researching and developing innovative pharmaceutical products to combat the virus, to providing exceptional healthcare services to patients. And this year, Dotmatics was named the “Best Scientific R&D Software Developer & Cloud Vendor.”
“The pandemic put a big spotlight on a pain that already existed, and pushed digital transformation to the forefront of many companies’ strategic initiatives,” said Steve Tharp, SVP Customer Ops at Dotmatics. “Whether focused on COVID-19, cancer research or food scarcity, we know that scientists struggle with their data stuck in silos. We’re working to build the first true end-to-end solution for scientific R&D to better support scientists committed to all manner of life-saving discoveries.”
The Dotmatics team is developing an integrated R&D platform with the depth, breadth, and connectivity to the best scientific applications to help solve the complex data challenges scientists face in lab environments. More than 2 million scientists and 10,000 customers trust Dotmatics to help them create a healthier, cleaner, safer world. Our global team of more than 800 people is dedicated to supporting our customers in over 180 countries.
Related
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
About Dotmatics
Dotmatics is a science-driven company with a mission to build the world’s most powerful scientific R&D platform by uniting best-in-class software applications into a flexible, data-driven ecosystem used by over 2 million scientists worldwide, enabling collaboration, automation, and analysis to accelerate innovation and address global challenges in health, environment, and safety.
Dotmatics Set to Transform the Future of Scientific Software and Data Management
Dotmatics, formed from the merger of Insightful Science and Dotmatics, is launching a powerful integrated enterprise R&D platform combining its scientific software with popular applications like SnapGene, Geneious, and GraphPad Prism to address complex data challenges and accelerate scientific research and collaboration for over two million scientists and 10,000 customers worldwide.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Dotmatics Demo for Chemicals & Materials
Dotmatics offers the first true end-to-end scientific R&D software platform that digitizes and automates lab functions across multiple disciplines—including synthetic chemistry, polymer science, and materials innovation—enabling over 2 million researchers to access high-quality data, overcome informatics challenges, and accelerate multimodal discovery for chemicals and materials.
Optimizing Bial’s Life-Changing Drug R&D
Bial, a biopharmaceutical leader in neuroscience and rare diseases, overcame fragmented software and collaboration challenges by adopting Dotmatics' unified SaaS platform, which streamlined R&D workflows, enhanced data accessibility, reduced IT complexity, and enabled researchers to focus on developing life-changing treatments.